About Bloomage Biotechnology Corporation Limited Company

Founded in 2000, the company is a global leader in biotechnology and biomanufacturing. It was the first to achieve the biomanufacturing of hyaluronic acid, a core anti-aging ingredient, and has leveraged this competitive advantage to pioneer cutting-edge research in glycobiology and cell biology. The company now offers integrated solutions across four major business segments: raw materials, pharmaceuticals and medical aesthetics, dermatology, and nutritional science. Its core product portfolio includes raw material products, medical-device-end products, innovative translational dermatology solutions, and innovative translational nutrition products. Over the years, the company has been recognized as a National Enterprise Technology Center, a Key Laboratory for Cosmetic Raw Material Quality Control under the National Medical Products Administration (jointly established), and a Key Laboratory for Synthetic Biology of Bioactive Compounds in Shandong Province (under development), among other research platforms. It has also been honored as a National Manufacturing Single-Champion Demonstration Enterprise, recipient of the First Prize for Scientific and Technological Progress of Shandong Province, the Shandong Provincial Governor's Quality Award, a National Intellectual Property Advantage Enterprise, the "Best Practice Case for Sustainable Development of Listed Companies in 2025" awarded by the All-China Federation of Industry and Commerce, and one of the Top 100 Chinese Listed Companies in ESG for the 19th consecutive year.